Morepen Laboratories
Morepen Laboratories Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Morepen Laboratories
Start SIPMorepen Laboratories Investment Rating
-
Master Rating:
-
Morepen Laboratories has an operating revenue of Rs. 1,417.53 Cr. on a trailing 12-month basis. An annual revenue de-growth of -9% needs improvement, Pre-tax margin of 4% needs improvement, ROE of 5% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 50 which is a POOR score indicating inconsistency in earnings, a RS Rating of 19 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 110 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 337 | 345 | 383 | 274 | 342 |
| Operating Expenses Qtr Cr | 321 | 323 | 356 | 261 | 323 |
| Operating Profit Qtr Cr | 15 | 21 | 27 | 14 | 19 |
| Depreciation Qtr Cr | 5 | 5 | 4 | 4 | 5 |
| Interest Qtr Cr | 1 | 1 | 0 | 0 | 1 |
| Tax Qtr Cr | 3 | 5 | 6 | 3 | 2 |
| Net Profit Qtr Cr | 10 | 13 | 17 | 7 | 14 |
Morepen Laboratories Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 11
- Bearish Moving Average
- ___
- 5
- 20 Day
- ₹26.46
- 50 Day
- ₹26.62
- 100 Day
- ₹27.51
- 200 Day
- ₹30.08
- 20 Day
- ₹26.25
- 50 Day
- ₹26.54
- 100 Day
- ₹27.09
- 200 Day
- ₹29.14
Morepen Laboratories Resistance and Support
| Resistance | |
|---|---|
| First Resistance | ₹27.55 |
| Second Resistance | ₹28.15 |
| Third Resistance | ₹28.5 |
| RSI | 57.32 |
| MFI | 61.08 |
| MACD Single Line | -0.1 |
| MACD | 0.06 |
| Support | |
|---|---|
| First Resistance | ₹26.6 |
| Second Resistance | ₹26.25 |
| Third Resistance | ₹25.65 |
Morepen Laboratories Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 5,216,786 | 182,170,167 | 34.92 |
| Week | 4,629,520 | 163,514,653 | 35.32 |
| 1 Month | 2,340,629 | 95,614,691 | 40.85 |
| 6 Month | 5,698,721 | 140,701,428 | 24.69 |
Morepen Laboratories Result Highlights
Morepen Laboratories Synopsis
NSE-Medical-Diversified
Morepen Labs.Lt is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1338.88 Cr. and Equity Capital is Rs. 102.23 Cr. for the Year ended 31/03/2023. Morepen Laboratories Ltd. is a Public Limited Listed company incorporated on 01/12/1984 and has its registered office in the State of Himachal Pradesh, India. Company’s Corporate Identification Number(CIN) is L24231HP1984PLC006028 and registration number is 006028.| Market Cap | 1,388 |
| Sales | 1,339 |
| Shares in Float | 31.69 |
| No of funds | 41 |
| Yield |
| Book Value | 1.76 |
| U/D Vol ratio | 1.5 |
| LTDebt / Equity | |
| Alpha | -0.15 |
| Beta | 0.37 |
Morepen Laboratories
| Owner Name | Mar-23 | Dec-22 | Sep-22 | Jun-22 |
|---|---|---|---|---|
| Promoters | 38.22% | 38.22% | 38.22% | 36.74% |
| Mutual Funds | ||||
| Insurance Companies | 1.06% | 1.07% | 1.07% | 1.1% |
| Foreign Portfolio Investors | 0.96% | 0.89% | 1.15% | 0.95% |
| Financial Institutions/ Banks | 0.34% | 2.33% | 0.38% | 2.98% |
| Individual Investors | 45.04% | 44.03% | 43.63% | 40.91% |
| Others | 14.38% | 13.46% | 15.55% | 17.32% |
Morepen Laboratories Management
| Name | Designation |
|---|---|
| Mr. Sushil Suri | Chairman & Managing Director |
| Mr. Sanjay Suri | Whole Time Director |
| Mr. Manoj Joshi | Independent Director |
| Mr. Bhupender Raj Wadhwa | Independent Director |
| Mr. Sukhcharan Singh | Independent Director |
| Mr. Praveen Kumar Dutt | Independent Director |
| Mrs. Savita | Independent Director |
Morepen Laboratories Forecast
Price Estimates
Morepen Laboratories Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-05-16 | Audited Results | |
| 2023-02-13 | Quarterly Results | |
| 2022-11-10 | Quarterly Results | |
| 2022-07-29 | Quarterly Results | |
| 2022-05-05 | Audited Results |
Morepen Laboratories FAQs
What is Share Price of Morepen Laboratories ?
Morepen Laboratories share price is ₹27 As on 09 June, 2023 | 12:39
What is the Market Cap of Morepen Laboratories ?
The Market Cap of Morepen Laboratories is ₹1382.7 Cr As on 09 June, 2023 | 12:39
What is the P/E ratio of Morepen Laboratories ?
The P/E ratio of Morepen Laboratories is 35.8 As on 09 June, 2023 | 12:39
What is the PB ratio of Morepen Laboratories ?
The PB ratio of Morepen Laboratories is 1.8 As on 09 June, 2023 | 12:39